SEATTLE, Jan. 24, 2022 /PRNewswire/ -- According to Coherent Market Insights, the global trypsin market is estimated to be valued at US$ 42.95 million in 2021 and is expected to exhibit a CAGR of 4.3% during the forecast period (2021-2028).
Key Trends and Analysis of the Global Trypsin Market:
Major players operating in the market are focusing on facility expansion for research and development. For instance, on April 6, 2021, Promega Corporation, a Wisconsin-based manufacturer of enzymes and other products for biotechnology and molecular biology announced the opening of Kornberg Center, company's newly constructed research and development facility in Fitchburg, the U.S. The Arthur Kornberg building, will support key product and technology development in cellular and molecular biology, life science research, clinical diagnostic, genetic identification, scientific applications, and training.
Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4866
Key Market Takeaways:
The global trypsin market is expected to exhibit a CAGR of 4.3% during the forecast period due to increasing adoption of inorganic strategies such as acquisitions and collaborations by the key players. For instance, in June 2020, BBI Solution, a subsidiary of BBI Group announced that the company completed the acquisition of DIARECT AG, a biotechnology company. This will help BBI to expand its diagnostic reagent product portfolio in the global trypsin market.
Among product type, kits segment is estimated to hold a dominant position in the global trypsin market in 2021. Market players such as Thermo Fisher Scientific, Promega Corporation, Merck KGaA, and others are focusing on manufacturing trypsin kits, which reduce the preparation time of trypsin digest and provide reliable results. These kits can be used in protein identification and quantification. This is expected to drive the segment growth over the forecast period. For instance, the SMART Digest Trypsin Kit manufactured by Thermo Fisher Scientific, a U.S.-based medical device and reagent manufacturer, enables characterization and quantification of proteins with a preparation time of only 60 minutes.
On the basis of application, protein identification segment is estimated to account for the largest market share in the global trypsin market over the forecast period. Proteomic identification of proteins requires proteolytic digestion of proteins into peptides which can be done using trypsin. Proteomic identification is highly used for research purposes, and this is expected to drive the segment growth over the forecast period. For instance, Trypsin with ProteaseMAX Surfactant, manufactured by Promega Corporation, a U.S.-based biotechnology company, is a trypsin enhancer, which enables quicker digestion and recovery of proteins, which can then be identified using mass spectrometry.
Key players operating in the global trypsin market include Promega Corporation, Merck KgaA, Geno Technology Inc., USA, Thermo Fisher Scientific Inc., SignalChem Biotech Inc., Takara Bio Inc., Creative Enzymes, ProteoChem, Waters Corporation, Bioseutica, Bovogen Biologicals Pty Ltd., and BBI Solutions.
Request for Report Customization @ https://www.coherentmarketinsights.com/insight/request-customization/4866
Detailed Market Segmentation:
Global Trypsin Market, By Source:
- Bovine
- Porcine
Global Trypsin Market, By Product Type:
- Kits
- Reagents
Global Trypsin Market, By Application:
- Protein Identification
- Quantitative Analysis
- Differential Expression
- Post-translational Modifications
Global Trypsin Market, By End User:
- Academic & Research Institutes
- Pharmaceutical Companies
- Others
Global Trypsin Market, By Region:
- North America
- By Country:
- U.S.
- Canada
- Europe
- By Country:
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Country:
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
- By Country:
- GCC Countries
- Israel
- South Africa
- Rest of Middle East & Africa
Buy this Complete Report Now @ https://www.coherentmarketinsights.com/insight/buy-now/4866
Find related trending report below:
Immobilized Trypsin Market, By Types ((Digestion Time) (Immobilized Trypsin (2 - 18 hrs.), Immobilized Trypsin (30 minutes), and Immobilized Trypsin (15 minutes)), By Application (Protein Identification, Protein Characterization, Protein: Protein Interactions, and Others), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Mr. Shah
Senior Client Partner - Business Development
Coherent Market Insights
Phone:
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com
Follow Us: LinkedIn | Twitter
Logo: https://mma.prnewswire.com/media/902389/Coherent_Market_Insights_Logo.jpg
